Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Yates

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Rheumatology (Oxford, England)|March 31, 2022
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathyAlexander G S Oldroyd, James B Lilleker, Tania Amin, et al.
Wellcome Open Research|May 31, 2022
A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data ReportAnna Rowan, Chris Bates, William Hulme, et al.
The Lancet. Rheumatology|June 14, 2022
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platformBrian MacKenna, Nicholas A Kennedy, Amir Mehrkar, et al.
Annals of the Rheumatic Diseases|February 14, 2023
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registriesPedro M Machado, Martin Schäfer, Satveer K Mahil, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Rheumatology (Oxford, England)|March 31, 2022
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathyAlexander G S Oldroyd, James B Lilleker, Tania Amin, et al.
Wellcome Open Research|May 31, 2022
A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data ReportAnna Rowan, Chris Bates, William Hulme, et al.
The Lancet. Rheumatology|June 14, 2022
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platformBrian MacKenna, Nicholas A Kennedy, Amir Mehrkar, et al.
Annals of the Rheumatic Diseases|February 14, 2023
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registriesPedro M Machado, Martin Schäfer, Satveer K Mahil, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Pageof 9